In
allergy and
asthma, the fine balance between the T helper (Th) 1, Th2 and T regulatory
cytokine responses appears to be shifted towards Th2. Here, we report that synthetic
lipopeptides which contain the typical
lipid part of the
lipoprotein of gram-negative bacteria stimulate a distinct regulatory
cytokine pattern and inhibit several Th2 cell-related phenomena. The most potent analogue of synthetic
lipopeptides,
lipopeptide CGP 40774 (LP40) was not active in MyD88-deficient mice and stimulated
Toll-like receptor (TLR)-2, but not TLR-4. LP40 potentiated the production of IFN-gamma and
IL-10, but not
IL-4 and
IL-5 by human T cells. In addition, triggering of TLR-2 by
lipopeptides promoted the in vitro differentiation of naive T cells towards IL-10- and IFN-gamma-producing T cells and suppressed
IL-4 production by Th2 cells. Accordingly, LP40 inhibited
IgE production induced by
allergen,
anti-IgD antibody, Nippostrongylus brasiliensis or murine acquired immunodeficiency virus. Furthermore,
ovalbumin-induced lung eosinophilic
inflammation was abolished and Schistosoma mansoni egg-induced
granuloma size and eosinophil counts were suppressed in mice by LP40. These results demonstrate that stimulation of TLR-2 by
lipopeptides represents a novel way for possible treatment of
allergy and
asthma by regulating the disrupted
cytokine balance.